Posted On: 12/10/2013 7:37:30 AM
Post# of 63743
From Pharma PRs
- Emergent BioSolutions' Otlertuzumab (TRU-016) Shows Positive Results in Combination with Rituximab in People with CLL
7:00 am - Business Wire
(0)
(0)Scroll down for more posts ▼
